rhein has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F; Yao, C | 1 |
| Gao, Y; He, R; He, Z; Li, X; Liu, Y; Pan, S; Qin, R; Shi, C; Shi, X; Wang, M; Zhao, C; Zhou, M; Zhu, F | 1 |
| Dai, X; Huang, X; Kang, Y; Li, J; Liang, G; Lin, S; Xiang, Y; Xu, L; Yang, L; Zhao, C | 1 |
3 other study(ies) available for rhein and Pancreatic Neoplasms
| Article | Year |
|---|---|
Inhibition of hypoxia-induced HIF-1α-mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells.
Topics: Autophagy; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Pancreatic Neoplasms; Tumor Microenvironment | 2022 |
Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Oxaliplatin; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phytotherapy; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rheum | 2021 |
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
Topics: Animals; Anthraquinones; Apoptosis; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Mice; Pancreatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2019 |